{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:23:43Z","timestamp":1791156223844,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Binding Site"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Measurement of serum free light chains (FLC) including kappa FLC, lambda FLC, and calculated kappa to lambda FLC ratio play a vital role in the diagnosis, prognosis, and monitoring of plasma cell disorders. Recent concerns regarding upward drift in The Binding Site\u2019s kappa FLC measurements have prompted a reformulation of the kappa FLC calibrator by the manufacturer. This study aims to assess the impact of the reformulated\/new kappa FLC calibrator on both the kappa FLC reference interval (RI) and the FLC ratio diagnostic range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Healthy volunteers (n = 124) from 3 tertiary care medical centers had FLCs measured using both the new and the prior lot of kappa FLC calibrators on an Optilite analyzer (The Binding Site). All samples were screened for monoclonal proteins using capillary electrophoresis. Creatinine was measured to confirm renal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Comparison of kappa FLC values from the new vs prior calibrator demonstrated minimal differences. Neither calibrator was able to verify manufacturer-suggested RI in our study population. The proportion of samples that had FLC ratios within the manufacturer\u2019s claimed diagnostic range was equivalent between calibrators, with roughly 6% to 7% of study participants falling above the diagnostic range of 0.26 to 1.65.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The new reformulated kappa FLC calibrator from The Binding Site does not support verification of the manufacturer\u2019s claimed kappa FLC RI or improve the number of healthy patients falling within the FLC ratio diagnostic range. Both the kappa FLC RI and diagnostic range for FLC ratio should be reevaluated and updated in consensus guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfaf208","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:55:35Z","timestamp":1765630535000},"page":"599-605","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of Serum Kappa Free Light Chain Reference Interval Using a New Stabilized Calibrator"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-039X","authenticated-orcid":false,"given":"Derek","family":"Waggoner","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine , Miami, FL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0074-3344","authenticated-orcid":false,"given":"Katie","family":"Thoren","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine , Miami, FL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7590-2442","authenticated-orcid":false,"given":"Robert","family":"Maynard","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Kentucky , Lexington, KY ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-0609","authenticated-orcid":false,"given":"Kwaku","family":"Twum","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Boston University School of Medicine , Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7924-599X","authenticated-orcid":false,"given":"Nichole","family":"Korpi-Steiner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill , Chapel Hill, NC ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026050509524093700_jfaf208-B1","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1080\/00365513.2016.1210337","article-title":"Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions","volume":"245","author":"Milani","year":"2016","journal-title":"Scand J Clin Lab Investig Suppl"},{"key":"2026050509524093700_jfaf208-B2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"2026050509524093700_jfaf208-B3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"2026050509524093700_jfaf208-B4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clinbiochem.2018.06.003","article-title":"Reference intervals and diagnostic ranges for serum free \u03ba and free \u03bb immunoglobulin light chains vary by instrument platform: implications for classification of patient results in a multi-center study","volume":"58","author":"Cotten","year":"2018","journal-title":"Clin Biochem"},{"key":"2026050509524093700_jfaf208-B5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clinbiochem.2021.02.008","article-title":"Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines","volume":"92","author":"Morales-Garc\u00eda","year":"2021","journal-title":"Clin Biochem"},{"key":"2026050509524093700_jfaf208-B6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jalm.2019.029330","article-title":"Serum free light chain assay: shift toward a higher \u03ba\/\u03bb ratio","volume":"5","author":"Rindlisbacher","year":"2020","journal-title":"J Appl Lab Med"},{"key":"2026050509524093700_jfaf208-B7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/jalm\/jfaa093","article-title":"Free light chain assay drift: potential for misdiagnosis?","volume":"5","author":"Murray","year":"2020","journal-title":"J Appl Lab Med"},{"key":"2026050509524093700_jfaf208-B8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ajcp\/aqw099","article-title":"Serum free light chain assay and \u03ba\/\u03bb ratio performance in patients without monoclonal gammopathies: high false-positive rate","volume":"146","author":"Singh","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"2026050509524093700_jfaf208-B9","author":"The Binding Site Inc"},{"key":"2026050509524093700_jfaf208-B10","volume-title":"CLSI EP28-A3c: Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline","author":"CLSI","year":"2010","edition":"3rd Ed"},{"key":"2026050509524093700_jfaf208-B11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41408-022-00732-3","article-title":"Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study","volume":"12","author":"Long","year":"2022","journal-title":"Blood Cancer J"},{"key":"2026050509524093700_jfaf208-B12","doi-asserted-by":"crossref","first-page":"110604","DOI":"10.1016\/j.clinbiochem.2023.110604","article-title":"Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines","volume":"118","author":"Schroeder","year":"2023","journal-title":"Clin Biochem"},{"key":"2026050509524093700_jfaf208-B13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.2024026078","article-title":"Serum free light chains in a racially diverse population including African Americans and populations from South Africa","volume":"145","author":"Bertamini","year":"2025","journal-title":"Blood"},{"key":"2026050509524093700_jfaf208-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14740\/cmmr103","article-title":"Screening for light chain monoclonal gammopathy of undetermined significance: pseudo epidemic based on current diagnostic criteria","volume":"3","author":"Singh","year":"2025","journal-title":"Cell Mol Med Res"},{"key":"2026050509524093700_jfaf208-B15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1373\/clinchem.2018.299461","article-title":"Direct detection of monoclonal free light chains in serum by use of immunoenrichment-coupled MALDI-TOF mass spectrometry","volume":"65","author":"Sepiashvili","year":"2019","journal-title":"Clin Chem"},{"key":"2026050509524093700_jfaf208-B16","doi-asserted-by":"crossref","first-page":"e00256","DOI":"10.1016\/j.plabm.2021.e00256","article-title":"Multiple myeloma: detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains","volume":"27","author":"Wilhite","year":"2021","journal-title":"Pract Lab Med"},{"key":"2026050509524093700_jfaf208-B17","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1515\/cclm-2023-0473","article-title":"A universal reference interval for serum immunoglobulins free light chains may be outdated","volume":"61","author":"Fink","year":"2023","journal-title":"Clin Chem Lab Med"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/3\/599\/66428943\/jfaf208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/3\/599\/66428943\/jfaf208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:52:49Z","timestamp":1777989169000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/11\/3\/599\/8427175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,1,16]]},"published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfaf208","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,1,16]]}}}